Dolichol phosphate pathway

The Dolichol phosphate pathway is a fundamental metabolic sequence located in the endoplasmic reticulum (ER) that facilitates the biosynthesis of lipid-linked oligosaccharides (LLOs), which serve as the essential precursors for N-linked protein glycosylation (Helenius & Aebi, 2004). This pathway involves the sequential addition of sugars to a dolichol phosphate carrier, a process initiated by the enzyme UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1-phosphate transferase (DPAGT1). Proper functioning of this pathway is critical for protein folding, stability, and intracellular trafficking; consequently, genetic defects in its enzymes lead to a group of metabolic diseases known as Congenital Disorders of Glycosylation (Freeze, 2006). In oncology, the pathway is frequently upregulated to support the high demand for glycoproteins in rapidly proliferating cancer cells, making enzymes like DPAGT1 potential therapeutic targets (Luo et al., 2015). However, because the pathway is highly conserved and essential for all eukaryotic cells, pharmacological inhibitors like tunicamycin often exhibit significant systemic toxicity, limiting their clinical use primarily to research or highly targeted applications. Beyond cancer, the pathway is also a target for anti-infectives, as many viruses and bacteria rely on host or specialized glycosylation machinery for virulence (Eichler & Imperiali, 2005).

Other names

Dolichol-linked oligosaccharide biosynthesis pathwayN-linked glycosylation pathwayLLO pathwayDolichol cyclePolyisoprenoid-linked sugar pathway

Inhibition of the initial step of N-glycan assembly via DPAGT1 antagonism or sequestration of the dolichol phosphate carrier to prevent glycan chain elongation and transfer to nascent polypeptides.